Growth Metrics

Merck (MRK) Net Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -43.12%
Dec 31, 2025 -113.41%
Sep 30, 2025 34.10%
Jun 30, 2025 -19.67%
Mar 31, 2025 -14.49%
Dec 31, 2024 16.26%
Sep 30, 2024 19.02%
Jun 30, 2024 43.38%
Mar 31, 2024 -70.06%
Dec 31, 2023 -63.09%
Sep 30, 2023 4.09%
Jun 30, 2023 -41.43%
Mar 31, 2023 -11.75%
Dec 31, 2022 21.23%
Sep 30, 2022 121.93%
Jun 30, 2022 18.73%
Mar 31, 2022 -36.70%
Dec 31, 2021 -13.98%
Sep 30, 2021 3.25%
Jun 30, 2021 20.10%
Mar 31, 2021 -28.28%
Dec 31, 2020 -41.33%
Sep 30, 2020 -52.04%
Jun 30, 2020 51.80%
Mar 31, 2020 -37.37%
Dec 31, 2019 7.53%
Sep 30, 2019 -7.86%
Jun 30, 2019 25.24%
Mar 31, 2019 -12.35%
Dec 31, 2018 -33.59%
Sep 30, 2018 35.34%
Jun 30, 2018 -12.92%
Mar 31, 2018 -49.91%
Dec 31, 2017 13.68%
Sep 30, 2017 -42.28%
Jun 30, 2017 -31.81%
Mar 31, 2017 33.64%
Dec 31, 2016 -5.89%
Sep 30, 2016 -9.65%
Jun 30, 2016 -51.45%
Mar 31, 2016 9.89%
Dec 31, 2015 -0.23%
Sep 30, 2015 -9.34%
Jun 30, 2015 -25.80%
Mar 31, 2015 24.51%
Dec 31, 2014 21.99%
Sep 30, 2014 -27.22%
Jun 30, 2014 -24.26%
Mar 31, 2014 -36.69%